| First Author | Yokoyama Y | Year | 2022 |
| Journal | Biochem Biophys Res Commun | Volume | 629 |
| Pages | 47-53 | PubMed ID | 36099784 |
| Mgi Jnum | J:330189 | Mgi Id | MGI:7366685 |
| Doi | 10.1016/j.bbrc.2022.08.097 | Citation | Yokoyama Y, et al. (2022) A20 (Tnfaip3) expressed in CD4(+) T cells suppresses Th2 cell-mediated allergic airway inflammation in mice. Biochem Biophys Res Commun 629:47-53 |
| abstractText | A20 (Tnfaip3), a ubiquitin-editing enzyme, inhibits NF-kappaB signaling pathways in response to pro-inflammatory cytokines. Previous studies have proved the anti-inflammatory roles of A20 in various cell types, including T cells, B cells, dendritic cells, and intestinal epithelial cells. Moreover, recent studies have shown that A20 expressed in lung epithelial cells is required for LPS-induced protection from asthma. In humans, a single-nucleotide polymorphism in TNFAIP3 is associated with asthma risk. However, the role of A20 expressed in T cells in asthmatic responses has not been elucidated. We addressed this point by generating mice lacking A20 expression in T cells (CD4-CreA20 (fl/fl) mice). We found that house dust mite (HDM)-induced allergic airway inflammation, mucus production, airway hyperresponsiveness, and Th2 cytokine production were significantly exacerbated in CD4-CreA20 (fl/fl) mice compared with those in control A20 (fl/fl) mice. In vitro differentiation of Th2 cells but not of Th1 cells or Th17 cells was enhanced in CD4(+) T cells by the absence of A20. Consistently, enforced expression of A20 inhibited the differentiation of Th2 cells but not of Th1 cells or Th17 cells. Notably, the expression of GATA3 was significantly enhanced in A20-deficient CD4(+) T cells, and the enhanced GATA3 expression was partly canceled by IL-2 neutralization. These results suggest that A20 functions as a stabilizing factor maintaining GATA3 levels during the induction of Th2 cells to prevent excessive Th2 cell differentiation. |
